Chemoinformaics analysis of Monocrotaline N-oxide
| Molecular Weight | 341.36 | nRot | 0 |
| Heavy Atom Molecular Weight | 318.176 | nRig | 20 |
| Exact Molecular Weight | 341.147 | nRing | 3 |
| Solubility: LogS | -1.051 | nHRing | 3 |
| Solubility: LogP | -0.085 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 48.7702 |
| nHD | 2 | BPOL | 30.2898 |
| QED | 0.267 |
| Synth | 5.711 |
| Natural Product Likeliness | 3.086 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.984 |
| HIA | 0.974 |
| CACO-2 | -5.749 |
| MDCK | 0.000833148 |
| BBB | 0.187 |
| PPB | 0.135068 |
| VDSS | 0.58 |
| FU | 0.86459 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.091 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.199 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.098 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.244 |
| CL | 3.824 |
| T12 | 0.932 |
| hERG | 0.005 |
| Ames | 0.007 |
| ROA | 0.424 |
| SkinSen | 0.071 |
| Carcinogencity | 0.89 |
| EI | 0.013 |
| Respiratory | 0.404 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.762149 |